The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Tropical disease drug discovery is an interdisciplinary field at the intersection of medicinal chemistry, computational biology, and global health. Despite ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...